Probable arabinosyltransferase A · SINGLE PROTEIN · Mycobacterium tuberculosis
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Probable arabinosyltransferase A shows approved-linked disease relevance led by pulmonary tuberculosis. 3 more disease programs remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P9WNL9. Start with pulmonary tuberculosis, then reuse UniProt P9WNL9 as the stable protein anchor across project notes and exports.
Start with pulmonary tuberculosis, then reuse UniProt P9WNL9 as the stable protein anchor across project notes and exports.
Probable arabinosyltransferase A shows approved-linked disease relevance led by pulmonary tuberculosis. 3 more disease programs remain visible in the same review block. 1 linked drug remains visible in the same block.
Start review with pulmonary tuberculosis because it currently carries approved-linked support. Linked drugs include ETHAMBUTOL HYDROCHLORIDE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyProbable arabinosyltransferase A
Review this target as Probable arabinosyltransferase A, mapped to UniProt P9WNL9. Sequence length is 1094 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Probable arabinosyltransferase A as ChEMBL target CHEMBL1877, mapped to UniProt P9WNL9. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Probable arabinosyltransferase A is the right protein anchor across sources, using UniProt P9WNL9 as the stable mapping.
Jump to Protein ContextUse this block first when you need to confirm why pulmonary tuberculosis is currently framed as approved-linked support. It currently carries 1 linked drug in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Probable arabinosyltransferase A |
| Target Type | SINGLE PROTEIN |
| Organism | Mycobacterium tuberculosis |
| UniProt | P9WNL9 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Probable arabinosyltransferase A |
| UniProt Accession | P9WNL9 |
| Component Type | Protein |
| Sequence Length | 1094 aa |
Probable arabinosyltransferase A
Review this target as Probable arabinosyltransferase A, mapped to UniProt P9WNL9. Sequence length is 1094 aa.
Open Targets-ready disease context using the current target-indication evidence contract.
Probable arabinosyltransferase A shows approved-linked disease relevance led by pulmonary tuberculosis. 3 more disease programs remain visible in the same review block.
Start review with pulmonary tuberculosis because it currently carries approved-linked support. Linked drugs include ETHAMBUTOL HYDROCHLORIDE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| single protein format | 2 | 3 | — |